GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation
Shenzhen-based DNA sequencer specialist GeneMind Biosciences Co., Ltd. has reportedly secured RMB 280 million (USD...
KingMed Diagnostics
AI in Healthcare: Accelerating Applications in Diagnostics and Multi-omics Analysis
The breakthrough technology of DeepSeek has significantly accelerated the application of AI in the medical...
Wuhan Union Hospital to Transfer Hereditary Thrombophilia Detection Patent to Kingmed Diagnostics
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, also recognized as Wuhan...
Sun Yat-sen University and KingMed Diagnostics Collaborate on Talent Development and Research
On June 20, 2024, the School of Public Health (Shenzhen) of Sun Yat-sen University and...
Kingmed Diagnostics Partners with GenStar Biosolutions to Develop Auto-Antibody Immunofluorescence AI Software
Kingmed Diagnostics, a leading independent medical laboratory based in Guangdong, has entered into a strategic...
Kingmed Diagnostics and MegaRobo Technologies Join Forces to Pioneer Smart Medical Laboratories
Kingmed Diagnostics (SHA: 603882), a prominent independent medical laboratory headquartered in Guangdong, is poised to...